IP Verse

Nep Inhibitors For Treating Diseases Characterized By Atrial Enlargement Or Remodeling - EP2887961

PATENT ANALYSIS

Patent Details

Grant Date
Apr 28, 2021
Company
NOVARTIS AG
Oppositions

ALFRED E. TIEFENBACHER (GMBH & CO. KG)

ALGEMEEN OCTROOI- EN MERKENBUREAU B.V.

GENERICS [UK] LIMITED

STADA ARZNEIMITTEL AG

TEVA PHARMACEUTICAL INDUSTRIES LTD

WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you